Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Regional Cell Preparation Center is a leading cell technology infrastructure and public service platform based in Shenzhen, China. Established and operated by Beike Biotechnology, it was the first regional cell preparation center approved in China, focusing on the standardized production, quality control, and storage of various cell products, including stem cells and immune cells. The center provides CDMO services and supports clinical research and applications in regenerative medicine and immunotherapy. It operates under high-level GMP standards and serves as a hub for the "Shenzhen Model" of the cell therapy industry, facilitating the translation of laboratory research into clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Regional Cell Production Center.